Martin A, Pellen P, Guitton C, Youinou P, Collet B, Desrues B, Bourel D, Dazord L, Toujas L
Centre Régional de Lutte contre le Cancer, Rennes, France.
Cancer Immunol Immunother. 1989;29(2):118-24. doi: 10.1007/BF00199286.
The mouse monoclonal antibody (mAb) Po66 has been shown in previous work to be localized in nude mice xenografts of human lung tumours when injected intravenously [Dazord L et al. (1987) Cancer Immunol Immunother 24: 263-268] and to be suitable for the scintigraphic detection of lung cancers in patients [Dazord L, et al. (1987) in Klapdor (ed) New tumour markers and their monoclonal antibodies. Georg Thieme, Stuttgart, New York, pp 444-450]. The nature of the antigen recognized by Po66 has been investigated in the present work and comparisons are made with antigens recognized by other mAbs prepared in the laboratory. These mAbs were raised either against lung squamous cell carcinoma (mAbs Po43, Po60), or against a bronchio-alveolar carcinoma (mAbs BAM33, BAM45, BAM54 and BAM69). Radioiodinated purified Po66 did not compete for cell binding with any other mAb. All Po and BAM mAbs reacted with tumour cells both cultured in vitro and grown in vivo. They recognized cytoplasmic antigens as judged by immunofluorescence examination of fixed cells or by immunoperoxidase staining of cancer tissues, but could never be visualized by immunofluorescence on the surface membrane of culture cells. The mAbs of the BAM series reacted with vimentin as demonstrated by immunofluorescence staining, showing alterations in the aspect of the filaments under the effect of colchicine. Radiolabelled mAbs Po43, BAM33 and BAM45 bound to partially purified cytoplasmic cytoskeleton components. In contrast, Po66 was never seen associated with intermediary filaments. The sensitivity to enzyme digestion of the antigen associated with Po66 was studied in comparison with those associated with Po43, BAM33 and BAM45. All antigens were sensitive to protease digestion while only the Po66-identified antigen was sensitive to periodate, neuraminidase and alpha-fucosidase. Thus, mAb Po66 identified an antigen of 47 kDa (as determined before) present in the cytoplasm but not related to the cytoskeleton, not detected on the cell surface and glycoprotein in nature.
小鼠单克隆抗体(mAb)Po66在先前的研究中已表明,静脉注射后可定位于人肺肿瘤的裸鼠异种移植瘤中[达佐德L等人(1987年),《癌症免疫与免疫治疗》24: 263 - 268],且适用于患者肺癌的闪烁显像检测[达佐德L等人(1987年),载于克拉普多(编)《新肿瘤标志物及其单克隆抗体》。乔治·蒂姆出版社,斯图加特,纽约,第444 - 450页]。在本研究中对Po66识别的抗原性质进行了研究,并与实验室制备的其他单克隆抗体识别的抗原进行了比较。这些单克隆抗体有的是针对肺鳞状细胞癌制备的(mAbs Po43、Po60),有的是针对支气管肺泡癌制备的(mAbs BAM33、BAM45、BAM54和BAM69)。放射性碘化纯化的Po66在细胞结合方面不与任何其他单克隆抗体竞争。所有Po和BAM单克隆抗体都能与体外培养和体内生长的肿瘤细胞发生反应。通过对固定细胞的免疫荧光检查或癌症组织的免疫过氧化物酶染色判断,它们识别细胞质抗原,但在培养细胞的表面膜上从未通过免疫荧光观察到。BAM系列单克隆抗体通过免疫荧光染色证明与波形蛋白发生反应,显示在秋水仙碱作用下细丝形态发生改变。放射性标记的单克隆抗体Po43、BAM33和BAM45与部分纯化的细胞质细胞骨架成分结合。相比之下,从未观察到Po66与中间丝相关。与Po43、BAM33和BAM45相关的抗原相比,研究了与Po66相关的抗原对酶消化的敏感性。所有抗原都对蛋白酶消化敏感,而只有Po66识别的抗原对高碘酸盐、神经氨酸酶和α - 岩藻糖苷酶敏感。因此,单克隆抗体Po66识别一种47 kDa的抗原(如之前所确定),该抗原存在于细胞质中,与细胞骨架无关,在细胞表面未检测到,本质上是糖蛋白。